NIH-funded research NIH-funded research

Investigating brain activity tracking in movement disorders using implanted sensors

Official title: An investigation into chronic implanted subgaleal electroencephalography for neurophysiological biomarker tracking in movement disorders

Funded at University of California, San Francisco · NIH-10893983 · Data updated 2026-11-12

This study is looking at how a protein called ubiquilin-2 interacts with clumps of proteins in diseases like Alzheimer's and Parkinson's, and it involves placing small sensors under the scalp to monitor brain activity, which could help find new ways to treat these conditions and improve patients' lives.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startJuly 1, 2020
Project endJune 30, 2026
Funding year2024
Award (this year)$92,192
NIH project number5K00NS118719-05
Project IDNIH-10893983 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias, as well as those with movement disorders like Parkinson's disease.

Less likely to help

Patients with movement disorders not related to neurodegenerative diseases or those without a diagnosis of Alzheimer's or related dementias may not benefit from this research.

What this research studies

This research focuses on understanding how a specific protein, ubiquilin-2, interacts with aggregated proteins in neurodegenerative diseases like Alzheimer's and Parkinson's. By using implanted subgaleal electroencephalography, the study aims to track neurophysiological biomarkers that could provide insights into movement disorders. Patients may have sensors placed under their scalp to monitor brain activity and protein interactions over time, helping researchers understand the underlying mechanisms of these diseases. The goal is to identify potential therapeutic targets that could improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that better manage or even reverse symptoms of movement disorders associated with neurodegenerative diseases.

How similar studies have gone: Previous research has shown promising results in understanding protein interactions in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Sandoval-Pistorius, Stephanie Suzette — University of California, San Francisco
  • Study coordinator: Sandoval-Pistorius, Stephanie Suzette

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.